Ancistrocladus ealaensis
Ancistrocladus ealaensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ancistrocladus ealaensis is a botanical species known for its unique pharmacological potential. Researchers have identified the leaf as a significant source of bioactive compounds within this plant. Specifically, the presence of the chemical Yaoundamine A distinguishes it from other related species. This particular compound is of great interest due to its potent antiplasmodial activities. Consequently, the plant serves as a vital subject in the ongoing search for new antimalarial treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ancistrocladaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Taxonomy
Ancistrocladus ealaensis is a unique biological entity that belongs to the vast kingdom Plantae. Within this expansive realm, the species is classified under the class Equisetopsida. It is further categorized into the order Caryophyllales, highlighting its specific evolutionary lineage. This plant is a member of the family Ancistrocladaceae, which showcases its distinct botanical traits. Finally, it is defined by its placement within the genus Ancistrocladus, completing its complex scientific identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Ancistrocladaceae |
| Genus | Ancistrocladus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ancistrocladus ealaensis is a specialized plant species primarily found within the dense ecosystems of West-Central Tropical Africa. Its natural distribution spans several key nations, including the Central African Republic and the Republic of the Congo. Furthermore, this species is established within the vast rainforest territories of the Democratic Republic of the Congo. The plant can also be found thriving in the tropical landscapes of Gabon. Together, these regions form the core geographic range for this unique botanical specimen.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ancistrocladus ealaensis is characterized by an obligatory climbing habit that allows it to ascend through its environment. Despite its climbing nature, this species typically reaches a maximum height of only 10 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ancistrocladus ealaensis is a Central African liana that has yielded a significant series of unique naphthylisoquinoline alkaloids. Researchers isolated ten compounds from its twigs and leaves, including a rare group of 7,8'-coupled "hybrid-type" alkaloids known as ealamines A-H. Among these newly discovered substances, ealamines A through D demonstrated distinct and specific antiplasmodial activities. Furthermore, these compounds showed a remarkable ability to target pancreatic cancer cells under nutrient-deprived conditions. This discovery highlights the immense pharmacological potential inherent within the chemical profile of this specific plant species.
Compounds
Ancistrocladus ealaensis is a Central African liana that serves as a rich source of diverse bioactive chemical compounds. Chemical analysis of the plant's twigs and leaves has led to the isolation of several notable substances, including ancistronaphthoic acid A and ancistronaphthoic acid B. Additionally, researchers have identified the presence of eleutherolic acid within its chemical profile. The plant also contains yaoundamine A, a compound previously documented in related African species. These various secondary metabolites highlight the complex phytochemical importance of this specific liana.
Conditions
Ancistrocladus ealaensis produces a series of unique 7,8'-coupled naphthylisoquinoline alkaloids known as ealamines. Within this group, ealamines A-D demonstrate distinct and specific antiplasmodial activities. Furthermore, these compounds exhibit pronounced preferential cytotoxic effects against PANC-1 human pancreatic cancer cells. This therapeutic potential is particularly notable when the cancer cells are in a nutrient-deprived medium. Among these substances, ealamine C stands out as the most potent agent for treating these specific conditions.
Preparations
Parts used
Ancistrocladus ealaensis is a Congolese liana that serves as a rich source of unique bioactive compounds. Researchers have successfully isolated a series of ten naphthylisoquinoline alkaloids from the plant's twigs and leaves. Among these findings, the newly identified ealamines A-H represent an unprecedented discovery of 7,8'-coupled structures. These specialized alkaloids, particularly ealamine C, demonstrate significant potential in targeting pancreatic cancer cells. Such findings highlight the pharmacological importance of the various parts of this specific African plant species.